Patents by Inventor Eleanor L. Schuler

Eleanor L. Schuler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170259073
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells.
    Type: Application
    Filed: March 21, 2017
    Publication date: September 14, 2017
    Inventor: Eleanor L. Schuler
  • Patent number: 9707403
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: July 18, 2017
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9636507
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: May 2, 2017
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Publication number: 20170028208
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Application
    Filed: August 8, 2016
    Publication date: February 2, 2017
    Inventor: Eleanor L. Schuler
  • Publication number: 20160331983
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Application
    Filed: May 16, 2016
    Publication date: November 17, 2016
    Inventor: Eleanor L. Schuler
  • Patent number: 9492478
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus of a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: November 15, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 9440083
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: September 13, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Publication number: 20160235783
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Application
    Filed: February 18, 2016
    Publication date: August 18, 2016
    Inventor: Eleanor L. Schuler
  • Patent number: 9295835
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus of a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: March 29, 2016
    Assignee: Neuro Code Tech Holdings, LLC
    Inventor: Eleanor L. Schuler
  • Publication number: 20150313537
    Abstract: Methods and systems for treating pancreatic cancer. A signal associated with pancreatic cancer in a body can be detected and recorded, and then reprogrammed to generate a confounding treatment signal with respect to the pancreatic cancer. The confounding treatment signal can be aimed at the pancreatic cancer in the body to shut down pancreatic cancer cells associated with said pancreatic cancer. The treatment signals can be provided as tiny encoded signals powered by ultra-low voltage approximated to the power level of the actual live pancreatic cancerous cell targets. An audio-light-optic system can seek out spreading pancreatic cancer cells that have moved onto nerves and blood vessels and the nearby organs, which include, for example, the liver, stomach, gall-bladder, spleen, and duodenum. Once the aberrant pancreatic cells are identified, the confounding treatment signals can be applied to destroy them.
    Type: Application
    Filed: April 23, 2015
    Publication date: November 5, 2015
    Inventor: Eleanor L. Schuler
  • Publication number: 20150258318
    Abstract: A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment.
    Type: Application
    Filed: March 12, 2015
    Publication date: September 17, 2015
    Inventor: Eleanor L. Schuler
  • Publication number: 20150231243
    Abstract: A bioelectronic medical method and system for rapidly destroying living cancer cells and the tumors they create including metastatic off-spring of such tumor(s) regardless of their location within a human or animal body. Calcium ions can be inserted into a nucleus of a cancer cell(s). The nucleus of the cancer cell(s) is then fragmented among many cancer cells (e.g., in a tumor) simultaneously with the transmission of a destructive analog electrically encoded signals to provide a medical cancer treatment thereof. A first target of medical cancer treatment is aimed principally into the nucleus and mitochondrion bodies of a malignancy associated with the cancer cell(s).
    Type: Application
    Filed: February 13, 2015
    Publication date: August 20, 2015
    Inventor: Eleanor L. Schuler
  • Publication number: 20140350637
    Abstract: Bioelectronics for controlling a skeletal muscle by means of a neuro-electrical coded signal. An actual neuro-coded signal that is naturally generated in a body and operative in control of a skeletal muscle can be collected from a nervous network and stored in a database associated with an electronic device. An implantable muscle control device having one or more electrodes can be directly attached to an appropriate nerve leading to one or more target skeletal muscles associated with a subject. The actual neuro-coded signal can be then selected from the database and broadcasted to the implantable device associated with the subject via a neuro-code transmission approach in order to activate and regulate the affected skeletal muscles.
    Type: Application
    Filed: June 9, 2014
    Publication date: November 27, 2014
    Inventor: Eleanor L. Schuler
  • Patent number: 8831738
    Abstract: A method and apparatus for recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. A confounding signal is created for retransmission into the cells of a malignant tumor to damage the cell and cause apoptosis. The invention uses ultra low voltage and current to cause apoptosis.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: September 9, 2014
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Patent number: 8818502
    Abstract: A method and device for endocrine and exocrine gland control. The method comprises selecting neuro-electrical coded signals from a storage area that are representative of body organ function. The selected neuro-electrical coded signals are then transmitted to a treatment member, which is in direct contact with the body, and which then broadcasts the neuro-electrical coded signals to a specific endocrine and exocrine gland nerve or gland to modulate the gland functioning. A control module is provided for transmission to the treatment member. The control module contains the neuro-electrical coded signals which are selected and transmitted to the treatment member, and computer storage can be provided for greater storage capacity and manipulation of the neuro-electrical coded signals.
    Type: Grant
    Filed: September 2, 2009
    Date of Patent: August 26, 2014
    Assignee: Codes of Life, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 8781593
    Abstract: A system and method for controlling a skeletal muscle by means of a neuro-electrical coded signal. An actual neuro-coded signal that is naturally generated in a body and operative in control of a skeletal muscle can be collected from a nervous network and stored in a database associated with an electronic device. An implantable muscle control device having one or more electrodes can be directly attached to an appropriate nerve leading to one or more target skeletal muscles associated with a subject. The actual neuro-coded signal can then be selected from the database and broadcasted to the implantable device associated with the subject via a neuro-code transmission approach in order to activate and regulate the affected skeletal muscles.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: July 15, 2014
    Assignee: Codes of Life, LLC
    Inventor: Eleanor L. Schuler
  • Patent number: 8656930
    Abstract: A scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 25, 2014
    Assignee: Neuro-Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8478398
    Abstract: Method and systems modulating eating behavior comprising (i) generating at least one confounding neuro-electrical signal that is adapted to modulate the sense of taste in the body, (ii) generating at least one confounding neuro-electrical signal that is adapted to modulate the sense of smell in the body, and (ii) transmitting at least one of the confounding neuro-electrical signals to a subject to modulate the subject's sense of taste or smell. In a preferred embodiment, both confounding neuro-electrical signals are transmitted to the subject to modulate the subject's sense of taste and smell.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: July 2, 2013
    Inventor: Eleanor L. Schuler
  • Patent number: 8467869
    Abstract: A method for modulating eating behavior comprising (i) generating at least one confounding neuro-electrical signal that is adapted to modulate the sense of taste in the body, (ii) generating at least one confounding neuro-electrical signal that is adapted to modulate the sense of smell in the body, and (iii) transmitting at least one of the confounding neuro-electrical signals to a subject to modulate the subject's sense of taste or smell. In a preferred embodiment, both confounding neuro-electrical signals are transmitted to the subject to modulate the subject's sense of taste and smell.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: June 18, 2013
    Inventor: Eleanor L. Schuler
  • Patent number: 8315712
    Abstract: A hybrid scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. Confounding electrical signals are stored in a scientific cancer cell signal processor of the computer system. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are re-programmed from cancer cell communication signals.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: November 20, 2012
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner